Biomaterials advances have had a huge impact on medicine during the last few decades, changing tissue engineering, drug delivery, immunological engineering, and medical device manufacturing. Advances in molecular self-assembly, polymer synthesis, protein and peptide engineering, and microfabrication technologies have resulted in the development of next-generation "smart" biomaterials that can adapt their chemical and mechanical properties in response to changes in physiological parameters and exogenous stimuli. Due to their capacity to respond to biological, chemical, and physical stimuli such as pH, redox potential, enzyme activity, temperature, humidity, light, sound, and stress, these materials are sought after for medical and tissue engineering applications. Smart biomaterials can respond to changes in physiological factors as well as exogenous stimuli, and they continue to have an impact on many facets of modern medicine. Smart materials have the potential to accelerate the development of promising medicines and enhance the treatment of chronic diseases. The insertion of certain functional groups into biomaterials allows control over their physical, chemical, and biological properties, according to one technique for the design of smart biomaterials for tissue engineering.
Title : Side effect free cancer chemotherapy by directed gene delivery using nanomaterials
A C Matin, Stanford University School of Medicine, United States
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : Novel gene therapy options for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Electroactive polymer-based smart scaffolds for tissue engineering and regenerative medicine
Federico Carpi, University of Florence, Italy
Title : Cellular and molecular profiling of critical bone fractures in axolotl
Polikarpova Anastasia, The Institute of Molecular Pathology, Austria